Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Clements

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Vaccine|November 10, 2009
Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxinNancy A Summerton, Richard W Welch, Laureano Bondoc, et al.
Blood|December 24, 2005
Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosaIgor M Belyakov, Vladimir A Kuznetsov, Brian Kelsall, et al.
CBE Life Sciences Education|December 4, 2013
Engaging actively with issues in the responsible conduct of science: lessons from international efforts are relevant for undergraduate education in the United StatesJohn D Clements, Nancy D Connell, Clarissa Dirks, et al.
Vaccine|March 22, 2002
The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvantAnthony H Choi, Monica M McNeal, Jason A Flint, et al.
Clinical and Vaccine Immunology : CVI|April 30, 2010
Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccineYing-Jie Lu, Puja Yadav, John D Clements, et al.
Journal of Virology|April 28, 2006
Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidatesJohn L VanCott, Anne E Prada, Monica M McNeal, et al.
Neurobiology of Disease|September 19, 2003
Evidence for peripheral clearance of cerebral Abeta protein following chronic, active Abeta immunization in PSAPP miceCynthia A Lemere, Edward T Spooner, John LaFrancois, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery systemJessica A White, Jeremy S Blum, Nancy A Hosken, et al.
Infection and Immunity|January 21, 2010
Assessment of the duration of protection in Campylobacter jejuni experimental infection in humansDavid R Tribble, Shahida Baqar, Daniel A Scott, et al.
Infection and Immunity|November 5, 2014
Impact of detergent on biophysical properties and immune response of the IpaDB fusion protein, a candidate subunit vaccine against Shigella speciesXiaotong Chen, Shyamal P Choudhari, Francisco J Martinez-Becerra, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Vaccine|November 10, 2009
Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxinNancy A Summerton, Richard W Welch, Laureano Bondoc, et al.
Blood|December 24, 2005
Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosaIgor M Belyakov, Vladimir A Kuznetsov, Brian Kelsall, et al.
CBE Life Sciences Education|December 4, 2013
Engaging actively with issues in the responsible conduct of science: lessons from international efforts are relevant for undergraduate education in the United StatesJohn D Clements, Nancy D Connell, Clarissa Dirks, et al.
Vaccine|March 22, 2002
The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvantAnthony H Choi, Monica M McNeal, Jason A Flint, et al.
Clinical and Vaccine Immunology : CVI|April 30, 2010
Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccineYing-Jie Lu, Puja Yadav, John D Clements, et al.
Journal of Virology|April 28, 2006
Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidatesJohn L VanCott, Anne E Prada, Monica M McNeal, et al.
Neurobiology of Disease|September 19, 2003
Evidence for peripheral clearance of cerebral Abeta protein following chronic, active Abeta immunization in PSAPP miceCynthia A Lemere, Edward T Spooner, John LaFrancois, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery systemJessica A White, Jeremy S Blum, Nancy A Hosken, et al.
Infection and Immunity|January 21, 2010
Assessment of the duration of protection in Campylobacter jejuni experimental infection in humansDavid R Tribble, Shahida Baqar, Daniel A Scott, et al.
Infection and Immunity|November 5, 2014
Impact of detergent on biophysical properties and immune response of the IpaDB fusion protein, a candidate subunit vaccine against Shigella speciesXiaotong Chen, Shyamal P Choudhari, Francisco J Martinez-Becerra, et al.
Pageof 9